$8.43
-0.16-1.86%
At close: -
$8.43
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Latest Amicus Therapeutics Stock News | NASDAQ:FOLD | Benzinga
Get the latest news on Amicus Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Amicus Therapeutics performance
Categories: All
Thursday, February 20, 2025
Wednesday, February 19, 2025
Wednesday, January 15, 2025
Monday, January 13, 2025
Friday, December 13, 2024
Tuesday, November 12, 2024
Thursday, November 07, 2024
Wednesday, November 06, 2024
Thursday, October 17, 2024
- Alnylam Stock Up on Cardiomyopathy Drug Regulatory Filing in the EU
- B of A Securities Maintains Buy on Amicus The...
- Amicus Therapeutics Settles Patent Lawsuit Teva Pharmaceuticals Over Generic Version Of Its Rare Genetic Disorder Drug
- Travelers Posts Upbeat Results, Joins Iridium Communications, Snap-on And Other Big Stocks Moving Higher On Thursday
- Amicus Therapeutics shares are trading higher...
- Amicus Therapeutics Enters License Agreement ...